Cleared Traditional

K121327 - DIOLASE 10S

K121327 is the FDA 510(k) clearance for DIOLASE 10S by Biolase Technology, Inc.. It is a Class 2 General & Plastic Surgery device (product code GEX) cleared through the Traditional 510(k) pathway after a 275-day FDA review.

K121327 · Biolase Technology, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2013
Decision
275d
Days
Class 2
Risk

K121327 is an FDA 510(k) clearance for the DIOLASE 10S. Classified as Powered Laser Surgical Instrument within the GEX classification (a category for powered laser surgical instruments across multiple specialties), Class II - Special Controls.

Submitted by Biolase Technology, Inc. (Irvine, US). The FDA issued a Cleared decision on February 1, 2013 after a review of 275 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4810 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Biolase Technology, Inc. devices

Submission Details

510(k) Number K121327 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 02, 2012
Decision Date February 01, 2013
Days to Decision 275 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
160d slower than avg
Panel avg: 115d · This submission: 275d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GEX Powered Laser Surgical Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4810
Definition A Laser (light Amplification By Stimulated Emission Of Radiation) Based Device Having Coherence, Collimated And Typically Monochromatic Radiation. Typically Indicated To To Cut, Destroy, Remove Or Coagulate Tissue, Generally Soft Tissue, For General Surgical Purpose In Medical Specialties Of General And Plastic Surgery, Dermatology/aesthetic, Podiatry, Otolaryngology (ent), Gynecology, Neurosurgery, Orthopedics (soft Tissue), Dental And Oral Surgery, And Dentistry. The Classification Regulation 21 Cfr 878.4810 Describes A Device That Is Carbon Dioxide Or Argon Laser Intended To Cut, Destroy, Remove Or Coagulate Tissue By The Light.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GEX Powered Laser Surgical Instrument

All 900
Devices cleared under the same product code (GEX) and FDA review panel - the closest regulatory comparables to K121327.
H-30 HOLMIUM LASER SYSTEM
K130444 · Cook, Inc. · May 2013
YOULASER CO2 LASER
K123573 · Quanta System Spa · Apr 2013
VENACURE EVLT NEVERTOUCH PROCEDURE KIT
K130671 · AngioDynamics, Inc. · Mar 2013
Q-PLUS T+ IPL LASER SYSTEM
K123168 · Quanta System Spa · Dec 2012
PICOSURE WORKSTATION
K121346 · Cynosure, Inc. · Nov 2012
ENDOBEAM HOLMIUM LASER FIBERS
K120926 · C.R. Bard, Inc. · Jul 2012